Baron & Budd Lipitor lawyers are looking into claims that Lipitor, a drug used to lower cholesterol levels, is allegedly associated with a higher risk of developing type 2 diabetes. If you or a loved one was diagnosed with type 2 diabetes while taking Lipitor, you may be able to file a Lipitor lawsuit.
Baron & Budd’s Lipitor lawyers are some of the most experienced in the country. With almost 40 years of experience protecting the rights of people against the wrongdoing of large companies, our law firm continues its strong track record today. In the 1990s our firm was instrumental in the litigation surrounding the diet drug Fen-Phen, resulting in a global settlement valued at over $1.275 billion.
More recently, our lawyers represented over 7,000 patients allegedly harmed by the diabetes drug Avandia. Our lawyers also represent numerous states in litigation against GlaxoSmithKline regarding the deceptive advertising of Avandia. Firm shareholder Burton LeBlanc was also appointed to serve on the leadership committee in the GranuFlo/NaturaLyte litigation known as the Plaintiffs Steering Committee (PSC). The PSC helps oversee all of the activities in the litigation and works on behalf of all consumers involved in the lawsuit.
Today, we can help you by looking into your patient history, answering your questions and providing you with the legal counsel you may need to find out if you are eligible for a Lipitor lawsuit. You should not have become diabetic because you took medication that you thought would help manage your cholesterol levels.
The brand name for the drug Atorvastatin, Lipitor is both manufactured and sold by the American pharmaceutical company Pfizer. Lipitor is part of the statin class of drugs, known as hypolipidemics, that was approved by the Food and Drug Administration (FDA) in 1996. Typically, Lipitor is prescribed in either 10 or 80 mg tablets that the patient ingests daily.
Type 2 diabetes is a serious medical condition involving the body’s inability to produce enough insulin to maintain healthy blood glucose levels. Unfortunately, type 2 diabetes is typically a life-long condition that is not reversible once the patient is diagnosed.
In addition to the risk of type 2 diabetes, moderate to severe side effects associated with the use of Lipitor include jaundice, muscle and liver problems, kidney failure and dark urine. Less serious side effects may include dizziness, nausea, diarrhea, indigestion, gas, incomplete and/or infrequent bowel movements, stomach cramps, joint pain, headaches, throat irritation and fatigue.
The Atherosclerosis Study
Published in 2010, the Atherosclerosis study looked at the metabolic effects of statins, narrowing in on what causes the onset of diabetes in patients. The study discovered that patients who take daily doses of Lipitor increase their risk of developing diabetes, even without pre-existing conditions that could contribute to developing diabetes.
The Journal of American College of Cardiology Study
Also, published in 2010, the JACC study looked at the dosage amounts of Lipitor and found that patients who take daily doses of Lipitor at 80 mg experience a higher risk of developing diabetes compared to a control group of patients who did not take daily Lipitor doses.
The Lancet Study
Published in 2011, The Lancet Study looked at several Lipitor-related studies and discovered that patients taking statin drugs such as Lipitor experience a 9 percent increased risk of developing type 2 diabetes.
What was the FDA’s response?
The FDA has required Pfizer, the pharmaceutical company that manufacturers Lipitor, to put warnings listing the serious side effects associated with Lipitor use, including the risk of increased blood sugar levels, on its label.
There was a Lipitor recall between August 2010 and December 2010 that is unrelated to the diabetes risk factor. This Lipitor recall occurred because some bottles containing the Lipitor drug reportedly had uncharacteristic smells. The smell was not found to cause side effects among patients taking the drug; however, it was still recalled in order to ensure proper packaging.
In addition, the generic version of Lipitor, a medicine called Atovastatin that is manufactured by the company Ranbaxy, was recalled in November 2012 after some bottles were found to contain very small glass particles. Again, this recall had nothing to do with the risk of developing diabetes.
Currently, Lipitor lawsuit claims require that the person filing the claim, the patient who used Lipitor, must have been diagnosed with type 2 diabetes while taking the drug. In addition, at this time the Lipitor lawsuit includes female patients only as women are more likely to be harmed by Lipitor’s type 2 diabetes risk. Baron & Budd is interested in representing women who had a Body Mass Index (BMI) of 32 or lower when they developed diabetes.